carbamazepine has been researched along with Aggression in 78 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Aggression: Behavior which may be manifested by destructive and attacking action which is verbal or physical, by covert attitudes of hostility or by obstructionism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy of oxcarbazepine (OXC) in the treatment of agitation and aggression in patients with Alzheimer's disease, vascular dementia or both." | 9.14 | Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. ( Aga, O; Cvancarova, M; Engedal, K; Olsen, IC; Selbaek, G; Sommer, OH, 2009) |
| "Oxcarbazepine appears to benefit adults with clinically significant impulsive aggression." | 9.11 | Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial. ( Mattes, JA, 2005) |
| "The aim of this study was to assess the effects of withdrawal from placebo and carbamazepine administered for agitation associated with dementia and to assess safety, tolerability, and efficacy of subsequent ongoing carbamazepine therapy." | 9.09 | Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, LJ; Lanning, B; Podgorski, CA; Tariot, PN, 1999) |
| "The efficacy, safety, and tolerability of carbamazepine in the treatment of agitation and aggression associated with dementia were assessed." | 9.08 | Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, L; Patel, S; Podgorski, CA; Tariot, PN, 1998) |
| " Risperidone is a widely accessible antipsychotic that can be used to manage psychosis-induced aggression or agitation." | 8.98 | Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Ahmed, U; Hussein, M; Miramontes, K; Ostinelli, EG; Rehman, FU, 2018) |
| "A 26-year-old man with bipolar disorder, seizures, and mild mental retardation secondary to a traumatic brain injury began treatment with carbamazepine for aggression and seizure control." | 7.75 | Carbamazepine-induced hyperammonemia. ( Adams, EN; Lizer, MH; Marks, A, 2009) |
| "Valproate and carbamazepine (CAR) have been proposed as adjunct alternatives for the control of aggression in psychiatric patients, although no definite conclusions have been reached." | 7.74 | Effects of sodium valproate and carbamazepine on food competition aggression in pigeons. ( Ahumada, M; Fachinelli, C; Fachinellizz, JM; Rodríguez-Echandía, EL; Torrecilla, M, 2007) |
| "Divalproex (DVP) and oxcarbazepine (OXC) are used to treat pediatric bipolar disorder (PBPD) with severe aggression but these agents have not been compared in head to head trials." | 7.73 | A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. ( Fleisher, CA; Gonzalez-Heydrich, J; Korndörfer, SR; MacMillan, CM; Mezzacappa, E; Rao, S, 2006) |
| "A chronic schizophrenic patient developed a fatal agranulocytosis 1 month after beginning to take carbamazepine for aggression." | 7.67 | Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine. ( Luchins, DJ, 1984) |
| "Carbamazepine was administered in an open pilot study to 13 patients with primary degenerative dementia characterized by aggressive and assaultive behavior refractory to conventional treatment." | 7.67 | A preliminary study of carbamazepine in the treatment of assaultive patients with dementia. ( Patterson, JF, 1988) |
| "Carbamazepine has been utilized both as an anticonvulsant and as a psychotropic drug for the treatment of complex partial seizures and various mood and other emotional disorders such as the episodic dyscontrol syndrome." | 5.27 | Carbamazepine regulates feline aggression elicited from the midbrain periaqueductal gray. ( Edinger, HM; Shaikh, MB; Siegel, A, 1988) |
| "Carbamazepine is an interesting new drug, with both anticonvulsant and psychotropic properties, for which both the behavioral effects and pharmacological actions have been defined." | 5.26 | Carbamazepine in the dyscontrol syndrome associated with limbic system dysfunction. ( Dermer, SW; Tunks, ER, 1977) |
| "To evaluate the efficacy of oxcarbazepine (OXC) in the treatment of agitation and aggression in patients with Alzheimer's disease, vascular dementia or both." | 5.14 | Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia. ( Aga, O; Cvancarova, M; Engedal, K; Olsen, IC; Selbaek, G; Sommer, OH, 2009) |
| "Oxcarbazepine appears to benefit adults with clinically significant impulsive aggression." | 5.11 | Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial. ( Mattes, JA, 2005) |
| "The aim of this study was to assess the effects of withdrawal from placebo and carbamazepine administered for agitation associated with dementia and to assess safety, tolerability, and efficacy of subsequent ongoing carbamazepine therapy." | 5.09 | Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, LJ; Lanning, B; Podgorski, CA; Tariot, PN, 1999) |
| "The efficacy, safety, and tolerability of carbamazepine in the treatment of agitation and aggression associated with dementia were assessed." | 5.08 | Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. ( Cox, C; Erb, R; Irvine, C; Jakimovich, L; Patel, S; Podgorski, CA; Tariot, PN, 1998) |
| " Risperidone is a widely accessible antipsychotic that can be used to manage psychosis-induced aggression or agitation." | 4.98 | Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation). ( Adams, CE; Ahmed, U; Hussein, M; Miramontes, K; Ostinelli, EG; Rehman, FU, 2018) |
| "To review and summarize the currently available data on the use of anticonvulsant mood stabilizers (carbamazepine, valproic acid, gabapentin, lamotrigine, topiramate) in the treatment of behavioral and psychological symptoms of dementia (BPSD); to determine whether these medications can be recommended for routine clinical use." | 4.84 | Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. ( Konovalov, S; Muralee, S; Tampi, RR, 2008) |
| "A 26-year-old man with bipolar disorder, seizures, and mild mental retardation secondary to a traumatic brain injury began treatment with carbamazepine for aggression and seizure control." | 3.75 | Carbamazepine-induced hyperammonemia. ( Adams, EN; Lizer, MH; Marks, A, 2009) |
| "Valproate and carbamazepine (CAR) have been proposed as adjunct alternatives for the control of aggression in psychiatric patients, although no definite conclusions have been reached." | 3.74 | Effects of sodium valproate and carbamazepine on food competition aggression in pigeons. ( Ahumada, M; Fachinelli, C; Fachinellizz, JM; Rodríguez-Echandía, EL; Torrecilla, M, 2007) |
| "Divalproex (DVP) and oxcarbazepine (OXC) are used to treat pediatric bipolar disorder (PBPD) with severe aggression but these agents have not been compared in head to head trials." | 3.73 | A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. ( Fleisher, CA; Gonzalez-Heydrich, J; Korndörfer, SR; MacMillan, CM; Mezzacappa, E; Rao, S, 2006) |
| "A chronic schizophrenic patient developed a fatal agranulocytosis 1 month after beginning to take carbamazepine for aggression." | 3.67 | Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine. ( Luchins, DJ, 1984) |
| "Carbamazepine was administered in an open pilot study to 13 patients with primary degenerative dementia characterized by aggressive and assaultive behavior refractory to conventional treatment." | 3.67 | A preliminary study of carbamazepine in the treatment of assaultive patients with dementia. ( Patterson, JF, 1988) |
| "Carbamazepine was not superior to placebo at optimal daily doses ranging from 400 to 800 mg, mean 683 mg, at serum levels of 4." | 2.68 | Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. ( Armenteros, JL; Campbell, M; Cueva, JE; Overall, JE; Perry, R; Small, AM, 1996) |
| "The diagnosis of attention deficit disorder predicted preferential response to propranolol, and a diagnosis of intermittent explosive disorder predicted preferential response to carbamazepine." | 2.67 | Comparative effectiveness of carbamazepine and propranolol for rage outbursts. ( Mattes, JA, 1990) |
| " Vegetative and neurotoxic effects most commonly occur in the beginning of therapy, after increasing the dosage and in case of intoxication." | 2.38 | [Carbamazepine in the treatment of psychiatric diseases: effects and side effects]. ( Rittmannsberger, H, 1990) |
| "Carbamazepine is a tricyclic compound structurally related to imipramine that has been used since the 1960's for the treatment of trigeminal neuralgias and then approved as an anticonvulsant in the U." | 2.37 | Carbamazepine in psychiatry: a review. ( Beaudry, P; Israel, M, 1988) |
| "Early treatment of epilepsy is warranted to avoid possible severe consequences." | 1.39 | Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle. ( Angeletti, G; Carbonetti, P; Del Casale, A; Fensore, C; Ferracuti, S; Girardi, P; Kotzalidis, GD; Lazanio, S; Muzi, A; Rapinesi, C; Savoja, V; Scatena, P; Serata, D; Tatarelli, R, 2013) |
| "Citalopram was the most preferred antidepressant and Carbamazepine, the most preferred mood stabilizer/antiepileptic." | 1.35 | Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey. ( Deb, S; Unwin, GL, 2008) |
| "Carbamazepine has been used in the treatment of temporal lobe epilepsy since 1963." | 1.27 | Carbamazepine in the treatment of aggressive behavior in schizophrenic patients: a case report. ( Dupont, D; Yassa, R, 1983) |
| "Carbamazepine is an interesting new drug, with both anticonvulsant and psychotropic properties, for which both the behavioral effects and pharmacological actions have been defined." | 1.26 | Carbamazepine in the dyscontrol syndrome associated with limbic system dysfunction. ( Dermer, SW; Tunks, ER, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 31 (39.74) | 18.7374 |
| 1990's | 24 (30.77) | 18.2507 |
| 2000's | 17 (21.79) | 29.6817 |
| 2010's | 6 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ostinelli, EG | 1 |
| Hussein, M | 1 |
| Ahmed, U | 1 |
| Rehman, FU | 1 |
| Miramontes, K | 1 |
| Adams, CE | 1 |
| Silva, EF | 1 |
| Silva, AI | 1 |
| Asth, L | 1 |
| Souza, LS | 1 |
| Zaveri, NT | 1 |
| Guerrini, R | 1 |
| Calo', G | 1 |
| Ruzza, C | 1 |
| Gavioli, EC | 1 |
| Rapinesi, C | 1 |
| Del Casale, A | 1 |
| Serata, D | 1 |
| Kotzalidis, GD | 1 |
| Scatena, P | 1 |
| Muzi, A | 1 |
| Lazanio, S | 1 |
| Savoja, V | 1 |
| Carbonetti, P | 1 |
| Fensore, C | 1 |
| Ferracuti, S | 1 |
| Angeletti, G | 1 |
| Tatarelli, R | 1 |
| Girardi, P | 1 |
| Meyer, JM | 1 |
| Cummings, MA | 1 |
| Proctor, G | 1 |
| Stahl, SM | 1 |
| Pae, CU | 1 |
| Sommer, OH | 1 |
| Aga, O | 1 |
| Cvancarova, M | 1 |
| Olsen, IC | 1 |
| Selbaek, G | 1 |
| Engedal, K | 1 |
| Adams, EN | 1 |
| Marks, A | 1 |
| Lizer, MH | 1 |
| Niederhofer, H | 1 |
| Mattes, JA | 5 |
| Richard, I | 1 |
| Perrouin-Verbe, B | 1 |
| Rome, J | 1 |
| Bernat, C | 1 |
| Mathé, JF | 1 |
| Gaudino, MP | 1 |
| Smith, MJ | 1 |
| Matthews, DT | 1 |
| Cummings, MR | 1 |
| Miller, BD | 1 |
| Stanford, MS | 1 |
| Helfritz, LE | 1 |
| Conklin, SM | 1 |
| Villemarette-Pittman, NR | 1 |
| Greve, KW | 2 |
| Adams, D | 2 |
| Houston, RJ | 1 |
| MacMillan, CM | 1 |
| Korndörfer, SR | 1 |
| Rao, S | 1 |
| Fleisher, CA | 1 |
| Mezzacappa, E | 1 |
| Gonzalez-Heydrich, J | 1 |
| Fachinelli, C | 1 |
| Ahumada, M | 1 |
| Fachinellizz, JM | 1 |
| Torrecilla, M | 1 |
| Rodríguez-Echandía, EL | 1 |
| Konovalov, S | 1 |
| Muralee, S | 1 |
| Tampi, RR | 1 |
| Nagata, T | 1 |
| Harada, D | 1 |
| Aoki, K | 1 |
| Kada, H | 1 |
| Miyata, H | 1 |
| Kasahara, H | 1 |
| Nakayama, K | 1 |
| Unwin, GL | 1 |
| Deb, S | 1 |
| Sheard, MH | 2 |
| Rapport, MD | 1 |
| Sonis, WA | 1 |
| Fialkov, MJ | 1 |
| Matson, JL | 1 |
| Kazdin, AE | 1 |
| Hoaken, PC | 1 |
| Tannhauser, SL | 1 |
| Tannhauser, M | 1 |
| Barros, HM | 1 |
| Corso, CO | 1 |
| Pinto-Netto, LM | 1 |
| Yassa, R | 1 |
| Dupont, D | 1 |
| Luchins, DJ | 1 |
| Bhatara, VS | 1 |
| Carrera, J | 1 |
| Young, JL | 1 |
| Hillbrand, M | 2 |
| Zayas, EM | 1 |
| Grossberg, GT | 1 |
| Mintzer, JE | 1 |
| Brawman-Mintzer, O | 1 |
| Chatham-Showalter, PE | 1 |
| Amen, DG | 1 |
| Stubblefield, M | 1 |
| Carmicheal, B | 1 |
| Thisted, R | 1 |
| Cueva, JE | 1 |
| Overall, JE | 1 |
| Small, AM | 2 |
| Armenteros, JL | 1 |
| Perry, R | 1 |
| Campbell, M | 3 |
| Kafantaris, V | 2 |
| Lee, DO | 1 |
| Magee, H | 1 |
| Winny, G | 1 |
| Samuel, R | 1 |
| Pollack, S | 1 |
| Tariot, PN | 2 |
| Erb, R | 2 |
| Podgorski, CA | 2 |
| Cox, C | 2 |
| Patel, S | 1 |
| Jakimovich, L | 1 |
| Irvine, C | 2 |
| Weller, EB | 1 |
| Rowan, A | 1 |
| Elia, J | 1 |
| Weller, RA | 1 |
| Swann, AC | 1 |
| Alderman, N | 1 |
| Davies, JA | 1 |
| Jones, C | 1 |
| McDonnel, P | 1 |
| Jakimovich, LJ | 1 |
| Lanning, B | 1 |
| Azouvi, P | 1 |
| Jokic, C | 1 |
| Attal, N | 1 |
| Denys, P | 1 |
| Markabi, S | 1 |
| Bussel, B | 1 |
| Teitelbaum, M | 1 |
| Vespignani, H | 1 |
| Roger, J | 1 |
| Brieden, T | 1 |
| Ujeyl, M | 1 |
| Naber, D | 1 |
| Tunks, ER | 1 |
| Dermer, SW | 1 |
| Sugarman, P | 1 |
| Anfinson, T | 1 |
| Tu, JB | 1 |
| Hartridge, C | 1 |
| Izawa, J | 1 |
| Padron-Gayol, MV | 1 |
| Locascio, JJ | 1 |
| Rosenberg, CR | 1 |
| Lewin, J | 1 |
| Sumners, D | 1 |
| Alarcon, RD | 1 |
| Johnson, BR | 1 |
| Lucas, JP | 1 |
| Wong, SE | 1 |
| Floyd, J | 1 |
| Innocent, AJ | 1 |
| Woolsey, JE | 1 |
| Rittmannsberger, H | 1 |
| Shah, AK | 1 |
| Marin, DB | 1 |
| Greenwald, BS | 1 |
| Foster, HG | 1 |
| Chi, CC | 1 |
| Fujiwara, Y | 1 |
| Takeda, T | 1 |
| Kazahaya, Y | 1 |
| Otsuki, S | 1 |
| Sandyk, R | 1 |
| Deutsch, SI | 1 |
| Risse, SC | 1 |
| Barnes, R | 1 |
| Ortiz, A | 1 |
| Gershon, S | 1 |
| Conacher, GN | 1 |
| Israel, M | 1 |
| Beaudry, P | 1 |
| Yatham, LN | 1 |
| McHale, PA | 1 |
| Buck, OD | 1 |
| Havey, P | 1 |
| Shaikh, MB | 1 |
| Edinger, HM | 1 |
| Siegel, A | 1 |
| Pleak, RR | 1 |
| Birmaher, B | 1 |
| Gavrilescu, A | 1 |
| Abichandani, C | 1 |
| Williams, DT | 1 |
| Patterson, JF | 1 |
| Weaver, DF | 1 |
| Camfield, P | 1 |
| Fraser, A | 1 |
| Leong, GB | 1 |
| Silva, JA | 1 |
| Gupta, BK | 1 |
| Fish, DN | 1 |
| Yerevanian, BI | 1 |
| Oehler, J | 1 |
| Jähkel, M | 1 |
| Schmidt, J | 1 |
| Nakao, K | 1 |
| Higashio, T | 1 |
| Inukai, T | 1 |
| Lehmann, HE | 1 |
| Ban, TA | 1 |
| Montanini, R | 1 |
| Mastruzzo, A | 1 |
| Giovannucci, M | 1 |
| Mourot, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Oxcarbazepine in the Treatment of Agitation / Aggression in Dementia (OBAD) - An Eight Week Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi Center Trial. A Phase III Study[NCT00145691] | Phase 3 | 100 participants | Interventional | 2005-09-30 | Completed | ||
| Carbamazepine for the Treatment of Chronic Post-Traumatic Brain Injury Irritability and Aggression: A 42-Day, Single-Site, Forced-Titration, Parallel Group, Randomized, Double-Blind, Placebo Controlled Trial[NCT00621751] | 70 participants (Actual) | Interventional | 2008-02-29 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Study physician's impression of change since study onset. Clinicians Global Impressions of Change (CGI) is a sensitive, standardized tool to assess psychopharmacologic treatment response completed by the study physician. The Global Improvement (GI) CGI subscale documented the clinician's impression of change. The GI uses a 7-point scale to assess beneficial and negative effects. Low GI values (1 -3) indicate improvement; higher values (4-7) represent worsening. (NCT00621751)
Timeframe: 42 days
| Intervention | units on a scale (Mean) |
|---|---|
| Carbamazepine | 3.1 |
| Placebo | 2.9 |
Global Impression of Change (GIC) is a 5-item Likert Scale rated participants and observer impression of change in the person with TBI. Responses range 1 = much improved to 5 = much worse. (NCT00621751)
Timeframe: 42 days
| Intervention | units on a scale (Mean) |
|---|---|
| Carbamazepine | 3.3 |
| Placebo | 3.1 |
Global Impression of Change (GIC) is a 5-item Likert Scale rated participants and observer impression of change in the person with TBI. Responses range 1 = much improved to 5 = much worse. (NCT00621751)
Timeframe: Day-42
| Intervention | score on a scale (Mean) |
|---|---|
| Carbamazepine | 3.1 |
| Placebo | 3.1 |
Neuropsychiatry Inventory-Irritability (NPI-I) & Aggression domains (NPI-A): NPI is a 40-item assessment of 12 behavioral domains (NPI-I & NPI-A domains used in this study). The most problematic aspect of each domain is graded for severity (1=mild, to 3=severe) and frequency (1-4 with 4 representing highest frequency); the domain scores (0-12) are the product of severity and frequency. To best reflect treatment target intent and meet parametric statistical method criteria, the primary outcome was a composite measure of observer-rated NPI-I & -A domains transformed to a Rasch logit scale running from 0 (best) to 100 (worse) units (i.e., observer-rated NPI-I/A Rasch construct scores). Mean day-42 observer-rated NPI-I/A Rasch construct scores were compared between placebo vs. carbamazepine using ANCOVA with baseline score as covariate. (NCT00621751)
Timeframe: 42 days
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Carbamazepine | 37.7 |
| Placebo | 36.7 |
Neuropsychiatry Inventory-Irritability (NPI-I) & Aggression domains (NPI-A): NPI is a 40-item assessment of 12 behavioral domains (NPI-I & NPI-A domains used in this study). The most problematic aspect of each domain is graded for severity (1=mild, to 3=severe) and frequency (1-4 with 4 representing highest frequency); the domain scores (0-12) are the product of severity and frequency. To best reflect treatment target intent and meet parametric statistical method criteria, a composite measure of participant-rated NPI-I & -A domains transformed to a Rasch logit scale running from 0 (best) to 100 (worse) units (i.e., participant-rated NPI-I/A Rasch construct scores). Mean day-42 participant-rated NPI-I/A Rasch construct scores were compared between placebo vs. CBZ using ANCOVA with baseline score as covariate. (NCT00621751)
Timeframe: Day 42
| Intervention | score on a scale (Least Squares Mean) |
|---|---|
| Carbamazepine | 37.5 |
| Placebo | 36.4 |
Proportion of participants with Minimal Clinically Important Difference (MCID) on Neuropsychiatric Inventory Irritability-Aggression Composite Measure completed by Observer. Specifically, the proportion of participants that experienced a decrease of > 1 (MCID) in the NPI-I/A Rasch construct score (i.e., participants that are considered to have meaningful reduction in irritability/aggression) from baseline to day-42 between the groups using a chi-square test. MCID was defined as 0.5 times the standard deviation of baseline scores. (NCT00621751)
Timeframe: 42-day
| Intervention | Participants (Count of Participants) |
|---|---|
| Carbamazepine | 20 |
| Placebo | 26 |
Proportion of participants with Minimal Clinically Important Difference (MCID) on Neuropsychiatric Inventory Irritability-Aggression Composite Measure completed by Participant. Specifically, the proportion of participants that experienced a decrease of > 1 (MCID) in the NPI-I/A Rasch construct score (i.e., participants that are considered to have meaningful reduction in irritability/aggression) from baseline to day-42 between the groups using a chi-square test. MCID was defined as 0.5 times the standard deviation of baseline scores. (NCT00621751)
Timeframe: Day-42
| Intervention | Participants (Count of Participants) |
|---|---|
| Carbamazepine | 21 |
| Placebo | 16 |
18 reviews available for carbamazepine and Aggression
| Article | Year |
|---|---|
Risperidone for psychosis-induced aggression or agitation (rapid tranquillisation).
Topics: Administration, Oral; Aggression; Antipsychotic Agents; Carbamazepine; Humans; Oxcarbazepine; Psycho | 2018 |
Psychopharmacology of Persistent Violence and Aggression.
Topics: Aggression; Antimanic Agents; Antipsychotic Agents; Brain Injuries, Traumatic; Carbamazepine; Clozap | 2016 |
[Pharmacological treatment of post-traumatic behavioural disorders].
Topics: Adrenergic beta-Antagonists; Aggression; Anti-Anxiety Agents; Antidepressive Agents; Antimanic Agent | 2003 |
Pharmacologic management of behavioral instability in medically ill pediatric patients.
Topics: Adolescent; Adrenergic alpha-Agonists; Aggression; Analgesics, Non-Narcotic; Behavior Therapy; Behav | 2004 |
Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review.
Topics: Aggression; Amines; Anticonvulsants; Carbamazepine; Cognition Disorders; Cyclohexanecarboxylic Acids | 2008 |
Clinical pharmacology of aggressive behavior.
Topics: Adolescent; Adult; Aged; Aggression; Anger; Anti-Anxiety Agents; Benzodiazepines; Brain Chemistry; C | 1984 |
Carbamazepine lowers aggression: a review.
Topics: Aggression; Carbamazepine; Epilepsy; Humans; Male; Mental Disorders | 1994 |
Agitation as a possible expression of generalized anxiety disorder in demented elderly patients: toward a treatment approach.
Topics: Aged; Aggression; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Buspirone; Carbamazepin | 1996 |
Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child D | 1999 |
Treatment of aggression in patients with bipolar disorder.
Topics: Aggression; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Combined Modality Therapy; Drug T | 1999 |
Psychopharmacological treatment of aggression in schizophrenic patients.
Topics: Adrenergic beta-Antagonists; Aggression; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Ca | 2002 |
[Carbamazepine in the treatment of psychiatric diseases: effects and side effects].
Topics: Affective Disorders, Psychotic; Aggression; Alcoholism; Carbamazepine; Humans; Mental Disorders; Psy | 1990 |
Pharmacologic treatment of agitation associated with dementia.
Topics: Affective Symptoms; Aged; Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antipsychotic Agents; | 1986 |
The future of neuroleptic psychopharmacology.
Topics: Acute Disease; Aggression; Alprazolam; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clinica | 1986 |
Clinical pharmacology of aggressive behavior.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aggression; Carbamazepine; Central Nervous System St | 1988 |
Carbamazepine in psychiatry: a review.
Topics: Aggression; Carbamazepine; Humans; Mental Disorders; Mood Disorders | 1988 |
Carbamazepine in the treatment of aggression: a case report and a review of the literature.
Topics: Adolescent; Aggression; Carbamazepine; Epilepsy, Temporal Lobe; Humans; Kindling, Neurologic; Limbic | 1988 |
Psychopharmacology of temper outbursts. A review.
Topics: Adolescent; Aggression; Anger; Animals; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind | 1986 |
11 trials available for carbamazepine and Aggression
| Article | Year |
|---|---|
Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Anticonvulsants; Carbamazepine; Dementia; De | 2009 |
A comparison of anticonvulsants in the treatment of impulsive aggression.
Topics: Adult; Aggression; Anticonvulsants; Carbamazepine; Double-Blind Method; Female; Humans; Impulsive Be | 2005 |
Oxcarbazepine in patients with impulsive aggression: a double-blind, placebo-controlled trial.
Topics: Adult; Aggression; Anticonvulsants; Carbamazepine; Disruptive, Impulse Control, and Conduct Disorder | 2005 |
Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study.
Topics: Aggression; Carbamazepine; Child; Child Behavior Disorders; Double-Blind Method; Female; Humans; Mal | 1996 |
Efficacy and tolerability of carbamazepine for agitation and aggression in dementia.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Carbamazepine; Dementia; Dementia, Vascular; | 1998 |
Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia.
Topics: Aggression; Anticonvulsants; Brief Psychiatric Rating Scale; Carbamazepine; Dementia; Drug Administr | 1999 |
Comparative effectiveness of carbamazepine and propranolol for rage outbursts.
Topics: Adolescent; Adult; Aggression; Antisocial Personality Disorder; Attention Deficit Disorder with Hype | 1990 |
Efficacy of carbamazepine in assaultive patients with frontal lobe dysfunction.
Topics: Adult; Affect; Aggression; Carbamazepine; Cognition Disorders; Electroencephalography; Frontal Lobe; | 1989 |
The future of neuroleptic psychopharmacology.
Topics: Acute Disease; Aggression; Alprazolam; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Clinica | 1986 |
Psychopharmacology of temper outbursts. A review.
Topics: Adolescent; Aggression; Anger; Animals; Carbamazepine; Child; Clinical Trials as Topic; Double-Blind | 1986 |
Studies with new drugs in the treatment of convulsive disorders.
Topics: Adult; Aggression; Anticonvulsants; Anxiety; Carbamazepine; Clinical Trials as Topic; Diazepam; Dibe | 1968 |
51 other studies available for carbamazepine and Aggression
| Article | Year |
|---|---|
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test.
Topics: Aggression; Agonistic Behavior; Animals; Anxiety; Bipolar Disorder; Carbamazepine; Cycloheptanes; De | 2019 |
Epilepsy and brain injury: a case report of a dramatic neuropsychiatric vicious circle.
Topics: Accidents, Traffic; Aggression; Amines; Anterior Temporal Lobectomy; Anticonvulsants; Brain Injuries | 2013 |
Effectiveness of carbamazepine for benzodiazepine-resistant impulsive aggression in a patient with frontal infarctions.
Topics: Aggression; Anticonvulsants; Benzodiazepines; Carbamazepine; Cerebral Infarction; Disruptive, Impuls | 2008 |
Carbamazepine-induced hyperammonemia.
Topics: Adult; Aggression; Akathisia, Drug-Induced; Antimanic Agents; Bipolar Disorder; Carbamazepine; Human | 2009 |
Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine.
Topics: Aggression; Antipsychotic Agents; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperac | 2011 |
Medications for aggressiveness in prison: focus on oxcarbazepine.
Topics: Aggression; Anticonvulsants; Carbamazepine; Humans; Mental Disorders; Oxcarbazepine; Prisoners | 2012 |
Use of oxcarbazepine for treatment-resistant aggression.
Topics: Adolescent; Adolescent Behavior; Aggression; Anticonvulsants; Attention Deficit and Disruptive Behav | 2003 |
A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder.
Topics: Adolescent; Adult; Aggression; Antidepressive Agents; Bipolar Disorder; Carbamazepine; Child; Drug A | 2006 |
Effects of sodium valproate and carbamazepine on food competition aggression in pigeons.
Topics: Aggression; Animals; Antimanic Agents; Carbamazepine; Columbidae; Competitive Behavior; Feeding Beha | 2007 |
Effectiveness of carbamazepine for benzodiazepine-resistant impulsive aggression in a patient with frontal infarctions.
Topics: Aggression; Antimanic Agents; Benzodiazepines; Carbamazepine; Cerebral Infarction; Drug Resistance; | 2007 |
Use of medication for the management of behavior problems among adults with intellectual disabilities: a clinicians' consensus survey.
Topics: Adult; Aggression; Antipsychotic Agents; Attitude of Health Personnel; Autistic Disorder; Carbamazep | 2008 |
Carbamazepine and behavior therapy for aggressive behavior. Treatment of a mentally retarded, postencephalitic adolescent with seizure disorder.
Topics: Adolescent; Aggression; Behavior Therapy; Carbamazepine; Combined Modality Therapy; Encephalitis; Ep | 1983 |
Carbamazepine in the treatment of aggressive behavior in schizophrenic patients: a case report.
Topics: Adult; Aggression; Bipolar Disorder; Carbamazepine; Humans; Male; Schizophrenia, Paranoid | 1984 |
Effects of carbamazepine or imipramine alone or in association with amphetamine on the fighting time of REM sleep-deprived rats.
Topics: Aggression; Animals; Carbamazepine; Dextroamphetamine; Humans; Imipramine; Male; Rats; Rats, Inbred | 1984 |
Carbamazepine in the treatment of aggressive behavior in schizophrenic patients: a case report.
Topics: Adult; Aggression; Carbamazepine; Combined Modality Therapy; Drug Therapy, Combination; Electroconvu | 1983 |
Fatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine.
Topics: Aggression; Agranulocytosis; Carbamazepine; Chronic Disease; Humans; Male; Middle Aged; Schizophreni | 1984 |
Medications for aggressiveness.
Topics: Aggression; Carbamazepine; Child; Child Behavior Disorders; Clonidine; Electroencephalography; Hallu | 1994 |
Treating the agitated Alzheimer patient.
Topics: Adrenergic beta-Antagonists; Aged; Aggression; Alzheimer Disease; Antipsychotic Agents; Buspirone; C | 1996 |
Carbamazepine for combativeness in acute traumatic brain injury.
Topics: Accidents, Traffic; Adult; Aggression; Brain Injuries; Carbamazepine; Critical Care; Female; Humans; | 1996 |
Brain SPECT findings and aggressiveness.
Topics: Adolescent; Adult; Aged; Aggression; Basal Ganglia; Brain; Carbamazepine; Case-Control Studies; Dang | 1996 |
Assessment of children with the overt aggression scale.
Topics: Aggression; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Female; Haloperidol; H | 1996 |
Reduction of severe aggressive behaviour in acquired brain injury: case studies illustrating clinical use of the OAS-MNR in the management of challenging behaviours.
Topics: Adult; Aggression; Antimanic Agents; Behavior Therapy; Brain Injury, Chronic; Carbamazepine; Combine | 1999 |
Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: results of an open trial.
Topics: Adult; Aged; Aggression; Anger; Antimanic Agents; Carbamazepine; Dose-Response Relationship, Drug; F | 1999 |
Oxcarbazepine in bipolar disorder.
Topics: Affect; Aggression; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Child; D | 2001 |
Treatment of features of Obsessive-Compulsive Personality Disorder using carbamazepine.
Topics: Aggression; Anticonvulsants; Attention; Carbamazepine; Humans; Male; Middle Aged; Motivation; Obsess | 2002 |
[Medico-legal aspects of temporal lobe epilepsy in prison].
Topics: Adult; Aggression; Anticonvulsants; Carbamazepine; Epilepsy, Temporal Lobe; Hallucinations; Health S | 2002 |
Carbamazepine in the dyscontrol syndrome associated with limbic system dysfunction.
Topics: Adult; Aggression; Agonistic Behavior; Brain Diseases; Carbamazepine; Electroencephalography; Female | 1977 |
Carbamazepine and episodic dyscontrol.
Topics: Adult; Aggression; Brain Damage, Chronic; Carbamazepine; Epilepsy; Humans; Male; Violence | 1992 |
Pharmacologic management of aggression and violence.
Topics: Adrenergic beta-Antagonists; Aggression; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Contr | 1992 |
Psychopharmacogenetic aspects of Prader-Willi syndrome.
Topics: Adolescent; Aggression; Appetite Depressants; Behavior Therapy; Carbamazepine; Combined Modality The | 1992 |
Carbamazepine in hospitalized aggressive conduct disorder children: an open pilot study.
Topics: Aggression; Carbamazepine; Child; Child Behavior Disorders; Child, Preschool; Female; Humans; Male | 1992 |
Successful treatment of episodic dyscontrol with carbamazepine.
Topics: Adolescent; Aggression; Brain Damage, Chronic; Carbamazepine; Dose-Response Relationship, Drug; Head | 1992 |
Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
Topics: Adolescent; Aggression; Carbamazepine; Child; Clomipramine; Dose-Response Relationship, Drug; Fluoxe | 1991 |
Applying a DRO schedule and compliance training to reduce aggressive and self-injurious behavior in an autistic man: a case report.
Topics: Adult; Aggression; Autistic Disorder; Behavior Therapy; Carbamazepine; Combined Modality Therapy; Ha | 1991 |
Violence in Alzheimer's disease.
Topics: Aged; Aggression; Alzheimer Disease; Carbamazepine; Electroencephalography; Humans; Violence | 1990 |
Carbamazepine for aggressive agitation in demented patients during nursing care.
Topics: Aged; Aggression; Alzheimer Disease; Carbamazepine; Female; Humans; Male; Psychomotor Agitation | 1989 |
Inhibitory effects of carbamazepine on clonidine-induced aggressive behavior in mice.
Topics: Adenosine; Aggression; Animals; Behavior, Animal; Caffeine; Carbamazepine; Clonidine; Haloperidol; M | 1988 |
Managing behavior in mentally retarded residential populations.
Topics: Adrenergic beta-Antagonists; Aggression; Antipsychotic Agents; Carbamazepine; Humans; Institutionali | 1986 |
Pharmacotherapy of the aggressive adult patient.
Topics: Adrenergic beta-Antagonists; Adult; Aggression; Carbamazepine; Dangerous Behavior; Humans; Lithium; | 1988 |
Combined carbamazepine and lithium therapy for violent behavior.
Topics: Adult; Aggression; Carbamazepine; Drug Synergism; Drug Therapy, Combination; Humans; Intellectual Di | 1986 |
Carbamazepine regulates feline aggression elicited from the midbrain periaqueductal gray.
Topics: Aggression; Agonistic Behavior; Animals; Carbamazepine; Cats; Electric Stimulation; Female; Male; Pe | 1988 |
Mania and neuropsychiatric excitation following carbamazepine.
Topics: Adolescent; Aggression; Akathisia, Drug-Induced; Attention Deficit Disorder with Hyperactivity; Bipo | 1988 |
A preliminary study of carbamazepine in the treatment of assaultive patients with dementia.
Topics: Aged; Aggression; Carbamazepine; Dementia; Dose-Response Relationship, Drug; Drug Administration Sch | 1988 |
Massive carbamazepine overdose: clinical and pharmacologic observations in five episodes.
Topics: Adolescent; Adult; Aggression; Ataxia; Carbamazepine; Chorea; Coma; Female; Hallucinations; Humans; | 1988 |
Carbamazepine use in assaultive patients.
Topics: Aggression; Carbamazepine; Humans; Neurocognitive Disorders; Pilot Projects | 1988 |
Carbamazepine for intermittent explosive disorder in a Prader-Willi syndrome patient.
Topics: Adult; Aggression; Carbamazepine; Disruptive, Impulse Control, and Conduct Disorders; Female; Humans | 1987 |
[Effect of lithium, carbamazepine, ca-valproate and diazepam on changes in social isolation-induced behavior in mice].
Topics: Aggression; Animals; Behavior, Animal; Carbamazepine; Diazepam; Lithium; Male; Mice; Motor Activity; | 1985 |
Metoprolol for intermittent explosive disorder.
Topics: Adult; Aggression; Anger; Carbamazepine; Humans; Male; Metoprolol; Neurocognitive Disorders; Propran | 1985 |
Antagonism of picrotoxin against the taming effect of carbamazepine on footshock induced fighting behavior in mice.
Topics: Aggression; Animals; Bicuculline; Carbamazepine; Diazepam; Electroshock; gamma-Aminobutyric Acid; Ha | 1985 |
[Clinical expressions of aggressive behavior and their treatment].
Topics: Aggression; Carbamazepine; Dibenzazepines; Humans; Mental Disorders; Nitriles; Phenothiazines; Piper | 1968 |
[Treatment of character disorders and subcritical epilepsy in adolescents].
Topics: Adolescent; Adult; Aggression; Carbamazepine; Epilepsy; Female; Humans; Male; Mental Disorders; Soci | 1973 |